Company:  OPGEN INC (OPGN)
Form Type:  DEFA14A
Filing Date:  10/29/2021 
CIK:  0001293818 
Address:  9717 KEY WEST AVENUE
SUITE 100
 
City, State, Zip:  ROCKVILLE, Maryland 20850 
Telephone:  301-869-9683 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.74  
Change: 
-0.07 (-3.87%)  
Trade Time: 
Feb 03  
Market Cap: 
$4.67M
Trade OPGN now with

© 2023  
Description of Business
Please refer to the Glossary at the end of this Business section for definitions or descriptions of scientific, diagnostic, healthcare, regulatory, and OpGen-specific terms used in this Annual Report. Overview OpGen, Inc. (the "Company") is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. Along with our subsidiaries, Curetis GmbH and Ares Genetics GmbH, we are developing and commercializing molecular microbiology solutions helping to guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.
Register and access this filing in:     
  FORM DEFA14A
    A Special Meeting of Stockholders of OpGen, Inc. will be held on


EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.